Schedule 13G ownership disclosure

RXI PHARMACEUTICALS CORP

Security class unavailable · CUSIP: 74979C303

Event date: 2014-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-15-000611
Form type
SC 13G/A
Filer
Phio Pharmaceuticals Corp.
CIK
CIK 1533040
Filed
Jan 27, 2015
Reporting period
Dec 31, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub